South KoreaHealthcare and life sciences2025 – ongoingGC Biopharma
Generative AI for pharmaceutical quality reports
GC Biopharma reported at least 80% less writing time for pharmaceutical quality reports
Problem
Staff manually assembled quality-report data from SAP and separate quality and laboratory systems. Report formats also varied between authors.
Approach
GC Biopharma worked with Megazone Cloud to build a drafting system using Megazone AIR. It combined Amazon Bedrock, Claude 3.7 and retrieval-augmented generation for annual product quality reviews and data trend analysis reports. Staff had to review drafts before completing reports.
Results
Takeaway
The reported saving concerned document writing. Human review remained a required step.
Categories
- Industry
- Healthcare and life sciences
- Business function
- Production and qualityInternal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Partner co-development
- Evidence
- Company's own claim
Sources
Source summaries
GC Biopharma reported at least 80% less writing time after introducing AI-assisted quality reports. The system generated drafts for mandatory review by staff.
GC again reported the quality-report system in operation at GC Biopharma. It repeated the writing-time reduction and described automated analysis of previously separate operational data.
Full details are in the original sources.
